Future health care leaders celebrated at Weill Cornell Commencement

Expected graduates from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences received their degrees during a digital commencement ceremony May 20.

Antibiotics don’t improve outcomes for rare lung disease

A phase 3 clinical trial of treatment for idiopathic pulmonary fibrosis, sponsored by Weill Cornell Medicine, could pave the way for cheaper studies that are easier to conduct.

AI technique detects cancer ‘drivers,’ ‘passengers’

A team led by researchers at Weill Cornell Medicine and their colleagues has developed a machine learning technique for identifying genetic mutations that trigger the disease.

Pilot program helps older adults with dementia manage meds

Serving residents of two upstate New York counties, the HOPES program led by Rana Zadeh is providing secure medication organizers and training to help prevent potentially dangerous and costly mishaps.

Grants to improve access to care for NYC blood cancer patients

A Weill Cornell Medicine research team will receive $1.3 million over five years to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.

Cerebral hemorrhage linked to stroke, cardiac risks

Weill Cornell Medicine researchers say the study’s findings suggest patients with brain bleeds should be screened more aggressively for problems related to clotting disorders.

Hanson, Grafstein elected to arts and sciences academy

Maureen Hanson, professor of molecular biology and genetics, and Bernice Grafstein, professor of neuroscience at Weill Cornell Medicine, have been elected to the American Academy of Arts and Sciences.

Vaccinated pregnant women pass antibodies to their babies

Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies to their babies.

Study reveals a cause of heart damage in COVID-19 patients

In the study, researchers at Weill Cornell Medicine and their colleagues also identified new potential treatments for COVID-19 patients and described a model for drug screening.